HEADER HYDROLASE 17-DEC-04 1YA4 TITLE CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE 1 IN COMPLEX WITH TITLE 2 TAMOXIFEN CAVEAT 1YA4 NAG A 1179 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CES1 PROTEIN; COMPND 3 CHAIN: A, B, C; COMPND 4 EC: 3.1.1.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS HYDROLASE DOMAIN, TAMOXIFEN COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.D.FLEMING,S.BENCHARIT,C.C.EDWARDS,J.L.HYATT,C.L.MORTON,E.L.HOWARD- AUTHOR 2 WILLIAMS,P.M.POTTER,M.R.REDINBO REVDAT 6 23-AUG-23 1YA4 1 HETSYN REVDAT 5 29-JUL-20 1YA4 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 13-JUL-11 1YA4 1 VERSN REVDAT 3 24-FEB-09 1YA4 1 VERSN REVDAT 2 13-SEP-05 1YA4 1 JRNL HETATM CONECT REVDAT 1 02-AUG-05 1YA4 0 JRNL AUTH C.D.FLEMING,S.BENCHARIT,C.C.EDWARDS,J.L.HYATT,L.TSURKAN, JRNL AUTH 2 F.BAI,C.FRAGA,C.L.MORTON,E.L.HOWARD-WILLIAMS,P.M.POTTER, JRNL AUTH 3 M.R.REDINBO JRNL TITL STRUCTURAL INSIGHTS INTO DRUG PROCESSING BY HUMAN JRNL TITL 2 CARBOXYLESTERASE 1: TAMOXIFEN, MEVASTATIN, AND INHIBITION BY JRNL TITL 3 BENZIL. JRNL REF J.MOL.BIOL. V. 352 165 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16081098 JRNL DOI 10.1016/J.JMB.2005.07.016 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2015598.680 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 34230 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2375 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5187 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE : 0.2860 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 391 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 12384 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 303 REMARK 3 SOLVENT ATOMS : 191 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -11.67000 REMARK 3 B22 (A**2) : 8.95000 REMARK 3 B33 (A**2) : 2.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.42 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.880 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.210 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.140 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.760 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.750 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.41 REMARK 3 BSOL : 42.20 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : TAX.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : TAX.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1YA4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-DEC-04. REMARK 100 THE DEPOSITION ID IS D_1000031307. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.022 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34502 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 20.00 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : 0.12000 REMARK 200 FOR THE DATA SET : 7.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.28600 REMARK 200 R SYM FOR SHELL (I) : 0.28600 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1MX1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM CHLORIDE, LITHIUM REMARK 280 CLORIDE, LITHIUM SULFATE, CITRATE, GLYCEROL, PH 5.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.68450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 100.79200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 89.97700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 100.79200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.68450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 89.97700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -123.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 21 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 367 C - N - CA ANGL. DEV. = 10.1 DEGREES REMARK 500 PRO B 23 C - N - CA ANGL. DEV. = 14.5 DEGREES REMARK 500 PRO B 367 C - N - CA ANGL. DEV. = 10.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 23 134.34 -31.80 REMARK 500 PHE A 76 -124.42 -107.56 REMARK 500 ASP A 90 108.68 -50.17 REMARK 500 LYS A 105 -74.79 -54.05 REMARK 500 SER A 113 149.04 -176.30 REMARK 500 LEU A 144 19.41 59.39 REMARK 500 ASN A 162 62.28 63.29 REMARK 500 SER A 185 73.18 -172.73 REMARK 500 ASN A 204 -39.12 -142.98 REMARK 500 ILE A 205 -15.92 -46.51 REMARK 500 SER A 214 54.26 -140.83 REMARK 500 SER A 221 -125.67 62.75 REMARK 500 LEU A 304 -4.05 62.47 REMARK 500 LEU A 318 -170.57 -173.02 REMARK 500 ARG A 339 0.85 -65.41 REMARK 500 TRP A 357 -62.77 -161.19 REMARK 500 SER A 365 94.93 57.68 REMARK 500 PRO A 367 11.83 -66.67 REMARK 500 LEU A 368 34.86 -89.59 REMARK 500 GLN A 375 -48.06 -25.24 REMARK 500 LYS A 402 -18.23 -48.24 REMARK 500 THR A 407 140.90 -32.79 REMARK 500 PHE A 426 -53.61 -121.01 REMARK 500 PRO A 515 176.80 -56.69 REMARK 500 ASN A 521 -147.87 -106.84 REMARK 500 ALA A 536 -166.85 -161.49 REMARK 500 LYS A 538 61.67 32.57 REMARK 500 LYS A 540 10.87 51.84 REMARK 500 PRO B 23 126.88 -1.40 REMARK 500 ALA B 44 -72.54 -61.28 REMARK 500 PRO B 59 49.29 -81.89 REMARK 500 PHE B 76 -120.52 -114.32 REMARK 500 LYS B 105 -70.80 -52.00 REMARK 500 SER B 113 148.69 -175.98 REMARK 500 CYS B 116 7.64 -152.12 REMARK 500 LEU B 127 -7.20 -56.96 REMARK 500 SER B 185 82.77 176.02 REMARK 500 ASN B 204 -36.97 -146.21 REMARK 500 SER B 221 -130.79 60.28 REMARK 500 SER B 253 -70.31 -20.75 REMARK 500 VAL B 254 -29.73 -31.81 REMARK 500 LYS B 302 68.31 36.15 REMARK 500 LEU B 304 9.84 52.32 REMARK 500 ARG B 339 1.30 -66.47 REMARK 500 TRP B 357 -70.22 -152.89 REMARK 500 SER B 365 66.46 66.92 REMARK 500 PRO B 367 -11.85 -49.75 REMARK 500 LEU B 368 65.56 -63.96 REMARK 500 GLN B 375 -50.72 -21.72 REMARK 500 CYS B 390 46.09 70.66 REMARK 500 REMARK 500 THIS ENTRY HAS 86 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MX1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH REMARK 900 TACRINE REMARK 900 RELATED ID: 1MX9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEXED WITH REMARK 900 NALOXONE METHIODIDE, A HEROIN ANALOGUE REMARK 900 RELATED ID: 1MX5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEXED WITH REMARK 900 HOMATROPINE, A COCAINE ANALOGUE REMARK 900 RELATED ID: 1YA8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH REMARK 900 CLEAVAGE PRODUCTS OF MEVASTATIN REMARK 900 RELATED ID: 1YAH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE COMPLEXED TO ETYL REMARK 900 ACETATE; A FATTY ACID ETHYL ESTER ANALOGUE REMARK 900 RELATED ID: 1YAJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH REMARK 900 BENZIL DBREF 1YA4 A 21 552 UNP P23141 EST1_HUMAN 21 552 DBREF 1YA4 B 21 552 UNP P23141 EST1_HUMAN 21 552 DBREF 1YA4 C 21 552 UNP P23141 EST1_HUMAN 21 552 SEQRES 1 A 532 SER SER PRO PRO VAL VAL ASP THR VAL HIS GLY LYS VAL SEQRES 2 A 532 LEU GLY LYS PHE VAL SER LEU GLU GLY PHE ALA GLN PRO SEQRES 3 A 532 VAL ALA ILE PHE LEU GLY ILE PRO PHE ALA LYS PRO PRO SEQRES 4 A 532 LEU GLY PRO LEU ARG PHE THR PRO PRO GLN PRO ALA GLU SEQRES 5 A 532 PRO TRP SER PHE VAL LYS ASN ALA THR SER TYR PRO PRO SEQRES 6 A 532 MET CYS THR GLN ASP PRO LYS ALA GLY GLN LEU LEU SER SEQRES 7 A 532 GLU LEU PHE THR ASN ARG LYS GLU ASN ILE PRO LEU LYS SEQRES 8 A 532 LEU SER GLU ASP CYS LEU TYR LEU ASN ILE TYR THR PRO SEQRES 9 A 532 ALA ASP LEU THR LYS LYS ASN ARG LEU PRO VAL MET VAL SEQRES 10 A 532 TRP ILE HIS GLY GLY GLY LEU MET VAL GLY ALA ALA SER SEQRES 11 A 532 THR TYR ASP GLY LEU ALA LEU ALA ALA HIS GLU ASN VAL SEQRES 12 A 532 VAL VAL VAL THR ILE GLN TYR ARG LEU GLY ILE TRP GLY SEQRES 13 A 532 PHE PHE SER THR GLY ASP GLU HIS SER ARG GLY ASN TRP SEQRES 14 A 532 GLY HIS LEU ASP GLN VAL ALA ALA LEU ARG TRP VAL GLN SEQRES 15 A 532 ASP ASN ILE ALA SER PHE GLY GLY ASN PRO GLY SER VAL SEQRES 16 A 532 THR ILE PHE GLY GLU SER ALA GLY GLY GLU SER VAL SER SEQRES 17 A 532 VAL LEU VAL LEU SER PRO LEU ALA LYS ASN LEU PHE HIS SEQRES 18 A 532 ARG ALA ILE SER GLU SER GLY VAL ALA LEU THR SER VAL SEQRES 19 A 532 LEU VAL LYS LYS GLY ASP VAL LYS PRO LEU ALA GLU GLN SEQRES 20 A 532 ILE ALA ILE THR ALA GLY CYS LYS THR THR THR SER ALA SEQRES 21 A 532 VAL MET VAL HIS CYS LEU ARG GLN LYS THR GLU GLU GLU SEQRES 22 A 532 LEU LEU GLU THR THR LEU LYS MET LYS PHE LEU SER LEU SEQRES 23 A 532 ASP LEU GLN GLY ASP PRO ARG GLU SER GLN PRO LEU LEU SEQRES 24 A 532 GLY THR VAL ILE ASP GLY MET LEU LEU LEU LYS THR PRO SEQRES 25 A 532 GLU GLU LEU GLN ALA GLU ARG ASN PHE HIS THR VAL PRO SEQRES 26 A 532 TYR MET VAL GLY ILE ASN LYS GLN GLU PHE GLY TRP LEU SEQRES 27 A 532 ILE PRO MET LEU MET SER TYR PRO LEU SER GLU GLY GLN SEQRES 28 A 532 LEU ASP GLN LYS THR ALA MET SER LEU LEU TRP LYS SER SEQRES 29 A 532 TYR PRO LEU VAL CYS ILE ALA LYS GLU LEU ILE PRO GLU SEQRES 30 A 532 ALA THR GLU LYS TYR LEU GLY GLY THR ASP ASP THR VAL SEQRES 31 A 532 LYS LYS LYS ASP LEU PHE LEU ASP LEU ILE ALA ASP VAL SEQRES 32 A 532 MET PHE GLY VAL PRO SER VAL ILE VAL ALA ARG ASN HIS SEQRES 33 A 532 ARG ASP ALA GLY ALA PRO THR TYR MET TYR GLU PHE GLN SEQRES 34 A 532 TYR ARG PRO SER PHE SER SER ASP MET LYS PRO LYS THR SEQRES 35 A 532 VAL ILE GLY ASP HIS GLY ASP GLU LEU PHE SER VAL PHE SEQRES 36 A 532 GLY ALA PRO PHE LEU LYS GLU GLY ALA SER GLU GLU GLU SEQRES 37 A 532 ILE ARG LEU SER LYS MET VAL MET LYS PHE TRP ALA ASN SEQRES 38 A 532 PHE ALA ARG ASN GLY ASN PRO ASN GLY GLU GLY LEU PRO SEQRES 39 A 532 HIS TRP PRO GLU TYR ASN GLN LYS GLU GLY TYR LEU GLN SEQRES 40 A 532 ILE GLY ALA ASN THR GLN ALA ALA GLN LYS LEU LYS ASP SEQRES 41 A 532 LYS GLU VAL ALA PHE TRP THR ASN LEU PHE ALA LYS SEQRES 1 B 532 SER SER PRO PRO VAL VAL ASP THR VAL HIS GLY LYS VAL SEQRES 2 B 532 LEU GLY LYS PHE VAL SER LEU GLU GLY PHE ALA GLN PRO SEQRES 3 B 532 VAL ALA ILE PHE LEU GLY ILE PRO PHE ALA LYS PRO PRO SEQRES 4 B 532 LEU GLY PRO LEU ARG PHE THR PRO PRO GLN PRO ALA GLU SEQRES 5 B 532 PRO TRP SER PHE VAL LYS ASN ALA THR SER TYR PRO PRO SEQRES 6 B 532 MET CYS THR GLN ASP PRO LYS ALA GLY GLN LEU LEU SER SEQRES 7 B 532 GLU LEU PHE THR ASN ARG LYS GLU ASN ILE PRO LEU LYS SEQRES 8 B 532 LEU SER GLU ASP CYS LEU TYR LEU ASN ILE TYR THR PRO SEQRES 9 B 532 ALA ASP LEU THR LYS LYS ASN ARG LEU PRO VAL MET VAL SEQRES 10 B 532 TRP ILE HIS GLY GLY GLY LEU MET VAL GLY ALA ALA SER SEQRES 11 B 532 THR TYR ASP GLY LEU ALA LEU ALA ALA HIS GLU ASN VAL SEQRES 12 B 532 VAL VAL VAL THR ILE GLN TYR ARG LEU GLY ILE TRP GLY SEQRES 13 B 532 PHE PHE SER THR GLY ASP GLU HIS SER ARG GLY ASN TRP SEQRES 14 B 532 GLY HIS LEU ASP GLN VAL ALA ALA LEU ARG TRP VAL GLN SEQRES 15 B 532 ASP ASN ILE ALA SER PHE GLY GLY ASN PRO GLY SER VAL SEQRES 16 B 532 THR ILE PHE GLY GLU SER ALA GLY GLY GLU SER VAL SER SEQRES 17 B 532 VAL LEU VAL LEU SER PRO LEU ALA LYS ASN LEU PHE HIS SEQRES 18 B 532 ARG ALA ILE SER GLU SER GLY VAL ALA LEU THR SER VAL SEQRES 19 B 532 LEU VAL LYS LYS GLY ASP VAL LYS PRO LEU ALA GLU GLN SEQRES 20 B 532 ILE ALA ILE THR ALA GLY CYS LYS THR THR THR SER ALA SEQRES 21 B 532 VAL MET VAL HIS CYS LEU ARG GLN LYS THR GLU GLU GLU SEQRES 22 B 532 LEU LEU GLU THR THR LEU LYS MET LYS PHE LEU SER LEU SEQRES 23 B 532 ASP LEU GLN GLY ASP PRO ARG GLU SER GLN PRO LEU LEU SEQRES 24 B 532 GLY THR VAL ILE ASP GLY MET LEU LEU LEU LYS THR PRO SEQRES 25 B 532 GLU GLU LEU GLN ALA GLU ARG ASN PHE HIS THR VAL PRO SEQRES 26 B 532 TYR MET VAL GLY ILE ASN LYS GLN GLU PHE GLY TRP LEU SEQRES 27 B 532 ILE PRO MET LEU MET SER TYR PRO LEU SER GLU GLY GLN SEQRES 28 B 532 LEU ASP GLN LYS THR ALA MET SER LEU LEU TRP LYS SER SEQRES 29 B 532 TYR PRO LEU VAL CYS ILE ALA LYS GLU LEU ILE PRO GLU SEQRES 30 B 532 ALA THR GLU LYS TYR LEU GLY GLY THR ASP ASP THR VAL SEQRES 31 B 532 LYS LYS LYS ASP LEU PHE LEU ASP LEU ILE ALA ASP VAL SEQRES 32 B 532 MET PHE GLY VAL PRO SER VAL ILE VAL ALA ARG ASN HIS SEQRES 33 B 532 ARG ASP ALA GLY ALA PRO THR TYR MET TYR GLU PHE GLN SEQRES 34 B 532 TYR ARG PRO SER PHE SER SER ASP MET LYS PRO LYS THR SEQRES 35 B 532 VAL ILE GLY ASP HIS GLY ASP GLU LEU PHE SER VAL PHE SEQRES 36 B 532 GLY ALA PRO PHE LEU LYS GLU GLY ALA SER GLU GLU GLU SEQRES 37 B 532 ILE ARG LEU SER LYS MET VAL MET LYS PHE TRP ALA ASN SEQRES 38 B 532 PHE ALA ARG ASN GLY ASN PRO ASN GLY GLU GLY LEU PRO SEQRES 39 B 532 HIS TRP PRO GLU TYR ASN GLN LYS GLU GLY TYR LEU GLN SEQRES 40 B 532 ILE GLY ALA ASN THR GLN ALA ALA GLN LYS LEU LYS ASP SEQRES 41 B 532 LYS GLU VAL ALA PHE TRP THR ASN LEU PHE ALA LYS SEQRES 1 C 532 SER SER PRO PRO VAL VAL ASP THR VAL HIS GLY LYS VAL SEQRES 2 C 532 LEU GLY LYS PHE VAL SER LEU GLU GLY PHE ALA GLN PRO SEQRES 3 C 532 VAL ALA ILE PHE LEU GLY ILE PRO PHE ALA LYS PRO PRO SEQRES 4 C 532 LEU GLY PRO LEU ARG PHE THR PRO PRO GLN PRO ALA GLU SEQRES 5 C 532 PRO TRP SER PHE VAL LYS ASN ALA THR SER TYR PRO PRO SEQRES 6 C 532 MET CYS THR GLN ASP PRO LYS ALA GLY GLN LEU LEU SER SEQRES 7 C 532 GLU LEU PHE THR ASN ARG LYS GLU ASN ILE PRO LEU LYS SEQRES 8 C 532 LEU SER GLU ASP CYS LEU TYR LEU ASN ILE TYR THR PRO SEQRES 9 C 532 ALA ASP LEU THR LYS LYS ASN ARG LEU PRO VAL MET VAL SEQRES 10 C 532 TRP ILE HIS GLY GLY GLY LEU MET VAL GLY ALA ALA SER SEQRES 11 C 532 THR TYR ASP GLY LEU ALA LEU ALA ALA HIS GLU ASN VAL SEQRES 12 C 532 VAL VAL VAL THR ILE GLN TYR ARG LEU GLY ILE TRP GLY SEQRES 13 C 532 PHE PHE SER THR GLY ASP GLU HIS SER ARG GLY ASN TRP SEQRES 14 C 532 GLY HIS LEU ASP GLN VAL ALA ALA LEU ARG TRP VAL GLN SEQRES 15 C 532 ASP ASN ILE ALA SER PHE GLY GLY ASN PRO GLY SER VAL SEQRES 16 C 532 THR ILE PHE GLY GLU SER ALA GLY GLY GLU SER VAL SER SEQRES 17 C 532 VAL LEU VAL LEU SER PRO LEU ALA LYS ASN LEU PHE HIS SEQRES 18 C 532 ARG ALA ILE SER GLU SER GLY VAL ALA LEU THR SER VAL SEQRES 19 C 532 LEU VAL LYS LYS GLY ASP VAL LYS PRO LEU ALA GLU GLN SEQRES 20 C 532 ILE ALA ILE THR ALA GLY CYS LYS THR THR THR SER ALA SEQRES 21 C 532 VAL MET VAL HIS CYS LEU ARG GLN LYS THR GLU GLU GLU SEQRES 22 C 532 LEU LEU GLU THR THR LEU LYS MET LYS PHE LEU SER LEU SEQRES 23 C 532 ASP LEU GLN GLY ASP PRO ARG GLU SER GLN PRO LEU LEU SEQRES 24 C 532 GLY THR VAL ILE ASP GLY MET LEU LEU LEU LYS THR PRO SEQRES 25 C 532 GLU GLU LEU GLN ALA GLU ARG ASN PHE HIS THR VAL PRO SEQRES 26 C 532 TYR MET VAL GLY ILE ASN LYS GLN GLU PHE GLY TRP LEU SEQRES 27 C 532 ILE PRO MET LEU MET SER TYR PRO LEU SER GLU GLY GLN SEQRES 28 C 532 LEU ASP GLN LYS THR ALA MET SER LEU LEU TRP LYS SER SEQRES 29 C 532 TYR PRO LEU VAL CYS ILE ALA LYS GLU LEU ILE PRO GLU SEQRES 30 C 532 ALA THR GLU LYS TYR LEU GLY GLY THR ASP ASP THR VAL SEQRES 31 C 532 LYS LYS LYS ASP LEU PHE LEU ASP LEU ILE ALA ASP VAL SEQRES 32 C 532 MET PHE GLY VAL PRO SER VAL ILE VAL ALA ARG ASN HIS SEQRES 33 C 532 ARG ASP ALA GLY ALA PRO THR TYR MET TYR GLU PHE GLN SEQRES 34 C 532 TYR ARG PRO SER PHE SER SER ASP MET LYS PRO LYS THR SEQRES 35 C 532 VAL ILE GLY ASP HIS GLY ASP GLU LEU PHE SER VAL PHE SEQRES 36 C 532 GLY ALA PRO PHE LEU LYS GLU GLY ALA SER GLU GLU GLU SEQRES 37 C 532 ILE ARG LEU SER LYS MET VAL MET LYS PHE TRP ALA ASN SEQRES 38 C 532 PHE ALA ARG ASN GLY ASN PRO ASN GLY GLU GLY LEU PRO SEQRES 39 C 532 HIS TRP PRO GLU TYR ASN GLN LYS GLU GLY TYR LEU GLN SEQRES 40 C 532 ILE GLY ALA ASN THR GLN ALA ALA GLN LYS LEU LYS ASP SEQRES 41 C 532 LYS GLU VAL ALA PHE TRP THR ASN LEU PHE ALA LYS MODRES 1YA4 ASN A 79 ASN GLYCOSYLATION SITE MODRES 1YA4 ASN B 79 ASN GLYCOSYLATION SITE MODRES 1YA4 ASN C 79 ASN GLYCOSYLATION SITE HET NAG A1179 14 HET SIA A1180 21 HET SO4 A1181 5 HET SO4 A1182 5 HET CTX A 1 28 HET CTX A 11 28 HET NAG B1279 14 HET SIA B1280 21 HET SO4 B1281 5 HET SO4 B1282 5 HET CTX B 2 28 HET CTX B1283 28 HET NAG C1379 14 HET SIA C1380 21 HET SO4 C1381 5 HET SO4 C1382 5 HET CTX C 3 28 HET CTX C1383 28 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM SIA N-ACETYL-ALPHA-NEURAMINIC ACID HETNAM SO4 SULFATE ION HETNAM CTX (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N- HETNAM 2 CTX DIMETHYLETHANAMINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN SIA N-ACETYLNEURAMINIC ACID; SIALIC ACID; ALPHA-SIALIC HETSYN 2 SIA ACID; O-SIALIC ACID HETSYN CTX TRANS FORM OF TAMOXIFEN FORMUL 4 NAG 3(C8 H15 N O6) FORMUL 5 SIA 3(C11 H19 N O9) FORMUL 6 SO4 6(O4 S 2-) FORMUL 8 CTX 6(C26 H29 N O) FORMUL 22 HOH *191(H2 O) HELIX 1 1 LEU A 60 ARG A 64 5 5 HELIX 2 2 ASP A 90 THR A 102 1 13 HELIX 3 3 GLY A 154 ASN A 162 1 9 HELIX 4 4 LEU A 172 PHE A 178 1 7 HELIX 5 5 ASN A 188 ILE A 205 1 18 HELIX 6 6 ALA A 206 PHE A 208 5 3 HELIX 7 7 SER A 221 SER A 233 1 13 HELIX 8 8 THR A 252 VAL A 254 5 3 HELIX 9 9 VAL A 261 ALA A 272 1 12 HELIX 10 10 THR A 278 LYS A 289 1 12 HELIX 11 11 THR A 290 MET A 301 1 12 HELIX 12 12 THR A 331 GLN A 336 1 6 HELIX 13 13 TRP A 357 MET A 364 1 7 HELIX 14 14 PRO A 367 GLY A 371 5 5 HELIX 15 15 ASP A 374 SER A 385 1 12 HELIX 16 16 SER A 385 CYS A 390 1 6 HELIX 17 17 LEU A 395 GLY A 405 1 11 HELIX 18 18 ASP A 409 PHE A 426 1 18 HELIX 19 19 PHE A 426 ASP A 439 1 14 HELIX 20 20 GLU A 471 PHE A 476 1 6 HELIX 21 21 GLY A 477 LEU A 481 5 5 HELIX 22 22 SER A 486 GLY A 507 1 22 HELIX 23 23 LYS A 540 ALA A 552 1 13 HELIX 24 24 LEU B 60 ARG B 64 5 5 HELIX 25 25 ASP B 90 THR B 102 1 13 HELIX 26 26 ALA B 148 TYR B 152 5 5 HELIX 27 27 GLY B 154 ASN B 162 1 9 HELIX 28 28 LEU B 172 PHE B 178 1 7 HELIX 29 29 ASN B 188 ASP B 203 1 16 HELIX 30 30 ASN B 204 PHE B 208 5 5 HELIX 31 31 SER B 221 SER B 233 1 13 HELIX 32 32 THR B 252 VAL B 254 5 3 HELIX 33 33 VAL B 261 ALA B 272 1 12 HELIX 34 34 THR B 278 LYS B 289 1 12 HELIX 35 35 THR B 290 MET B 301 1 12 HELIX 36 36 THR B 331 GLU B 338 1 8 HELIX 37 37 TRP B 357 MET B 364 1 7 HELIX 38 38 ASP B 374 SER B 385 1 12 HELIX 39 39 SER B 385 CYS B 390 1 6 HELIX 40 40 LEU B 395 GLY B 405 1 11 HELIX 41 41 ASP B 409 PHE B 426 1 18 HELIX 42 42 PHE B 426 ASP B 439 1 14 HELIX 43 43 GLU B 471 PHE B 476 1 6 HELIX 44 44 GLY B 477 LEU B 481 5 5 HELIX 45 45 SER B 486 GLY B 507 1 22 HELIX 46 46 LYS B 540 LYS B 553 1 14 HELIX 47 47 LEU C 60 ARG C 64 5 5 HELIX 48 48 ASP C 90 THR C 102 1 13 HELIX 49 49 GLY C 154 ASN C 162 1 9 HELIX 50 50 LEU C 172 PHE C 178 1 7 HELIX 51 51 ASN C 188 ASP C 203 1 16 HELIX 52 52 ASN C 204 PHE C 208 5 5 HELIX 53 53 SER C 221 SER C 233 1 13 HELIX 54 54 THR C 252 VAL C 256 5 5 HELIX 55 55 VAL C 261 ALA C 272 1 12 HELIX 56 56 THR C 278 LYS C 289 1 12 HELIX 57 57 THR C 290 LYS C 302 1 13 HELIX 58 58 THR C 331 GLU C 338 1 8 HELIX 59 59 TRP C 357 MET C 364 1 7 HELIX 60 60 ASP C 374 SER C 385 1 12 HELIX 61 61 SER C 385 CYS C 390 1 6 HELIX 62 62 LEU C 395 GLY C 405 1 11 HELIX 63 63 ASP C 409 PHE C 426 1 18 HELIX 64 64 PHE C 426 ASP C 439 1 14 HELIX 65 65 GLU C 471 PHE C 476 1 6 HELIX 66 66 GLY C 477 LYS C 482 1 6 HELIX 67 67 SER C 486 GLY C 507 1 22 HELIX 68 68 LYS C 540 ALA C 552 1 13 SHEET 1 A 3 VAL A 25 THR A 28 0 SHEET 2 A 3 GLY A 31 LEU A 34 -1 O VAL A 33 N VAL A 26 SHEET 3 A 3 VAL A 77 ASN A 79 1 O LYS A 78 N LEU A 34 SHEET 1 B11 LYS A 36 VAL A 38 0 SHEET 2 B11 VAL A 47 PRO A 54 -1 O VAL A 47 N VAL A 38 SHEET 3 B11 TYR A 118 THR A 123 -1 O ILE A 121 N PHE A 50 SHEET 4 B11 VAL A 164 ILE A 168 -1 O VAL A 165 N TYR A 122 SHEET 5 B11 LEU A 133 ILE A 139 1 N TRP A 138 O VAL A 166 SHEET 6 B11 GLY A 210 GLU A 220 1 O ASN A 211 N LEU A 133 SHEET 7 B11 ARG A 242 GLU A 246 1 O GLU A 246 N GLY A 219 SHEET 8 B11 TYR A 346 ASN A 351 1 O MET A 347 N ALA A 243 SHEET 9 B11 THR A 444 PHE A 449 1 O TYR A 445 N VAL A 348 SHEET 10 B11 GLY A 525 ILE A 529 1 O LEU A 527 N GLU A 448 SHEET 11 B11 GLN A 534 GLN A 537 -1 O ALA A 536 N TYR A 526 SHEET 1 C 2 VAL A 256 LYS A 257 0 SHEET 2 C 2 THR A 321 VAL A 322 1 O THR A 321 N LYS A 257 SHEET 1 D 3 VAL B 25 THR B 28 0 SHEET 2 D 3 GLY B 31 LEU B 34 -1 O VAL B 33 N VAL B 26 SHEET 3 D 3 VAL B 77 ASN B 79 1 O LYS B 78 N LEU B 34 SHEET 1 E11 LYS B 36 VAL B 38 0 SHEET 2 E11 VAL B 47 PRO B 54 -1 O VAL B 47 N VAL B 38 SHEET 3 E11 TYR B 118 THR B 123 -1 O ILE B 121 N PHE B 50 SHEET 4 E11 VAL B 164 ILE B 168 -1 O THR B 167 N ASN B 120 SHEET 5 E11 LEU B 133 ILE B 139 1 N TRP B 138 O VAL B 166 SHEET 6 E11 GLY B 210 GLU B 220 1 O THR B 216 N VAL B 135 SHEET 7 E11 ARG B 242 GLU B 246 1 O GLU B 246 N GLY B 219 SHEET 8 E11 TYR B 346 ASN B 351 1 O MET B 347 N ALA B 243 SHEET 9 E11 THR B 444 PHE B 449 1 O TYR B 445 N VAL B 348 SHEET 10 E11 GLY B 525 ILE B 529 1 O ILE B 529 N GLU B 448 SHEET 11 E11 GLN B 534 GLN B 537 -1 O ALA B 536 N TYR B 526 SHEET 1 F 2 VAL B 256 LYS B 257 0 SHEET 2 F 2 THR B 321 VAL B 322 1 O THR B 321 N LYS B 257 SHEET 1 G 3 VAL C 25 THR C 28 0 SHEET 2 G 3 GLY C 31 LEU C 34 -1 O VAL C 33 N VAL C 26 SHEET 3 G 3 VAL C 77 ASN C 79 1 O LYS C 78 N LEU C 34 SHEET 1 H11 LYS C 36 VAL C 38 0 SHEET 2 H11 VAL C 47 PRO C 54 -1 O VAL C 47 N VAL C 38 SHEET 3 H11 TYR C 118 THR C 123 -1 O THR C 123 N ALA C 48 SHEET 4 H11 VAL C 164 ILE C 168 -1 O THR C 167 N ASN C 120 SHEET 5 H11 LEU C 133 ILE C 139 1 N TRP C 138 O VAL C 166 SHEET 6 H11 GLY C 210 GLU C 220 1 O ASN C 211 N LEU C 133 SHEET 7 H11 ARG C 242 GLU C 246 1 O GLU C 246 N GLY C 219 SHEET 8 H11 TYR C 346 ASN C 351 1 O MET C 347 N ALA C 243 SHEET 9 H11 THR C 444 PHE C 449 1 O TYR C 445 N VAL C 348 SHEET 10 H11 GLY C 525 ILE C 529 1 O LEU C 527 N GLU C 448 SHEET 11 H11 GLN C 534 GLN C 537 -1 O GLN C 534 N GLN C 528 SSBOND 1 CYS A 87 CYS A 116 1555 1555 2.04 SSBOND 2 CYS A 274 CYS A 285 1555 1555 2.04 SSBOND 3 CYS B 87 CYS B 116 1555 1555 2.03 SSBOND 4 CYS B 274 CYS B 285 1555 1555 2.04 SSBOND 5 CYS C 87 CYS C 116 1555 1555 2.04 SSBOND 6 CYS C 274 CYS C 285 1555 1555 2.04 LINK ND2 ASN A 79 C1 NAG A1179 1555 1555 1.45 LINK ND2 ASN B 79 C1 NAG B1279 1555 1555 1.45 LINK ND2 ASN C 79 C1 NAG C1379 1555 1555 1.45 CRYST1 55.369 179.954 201.584 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018061 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005557 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004961 0.00000